PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase

Cited by (999)

Items 901–999 of 999

1. Integration of network toxicology, machine learning and single-cell sequencing reveals the effects of soil pollutants on prostate cancer
   Zhiyu Liu, Yuqi Li, Juan Wang, Yang Zeng, Qilong Wu, Xinyao Zhu, Tao Zhou, Qingfu Deng · 2025 · Ecotoxicology and Environmental Safety
2. Differential control of ageing and lifespan by isoforms and splice variants across the mTOR network
   Patricia Razquin Navas, Kathrin Thedieck · 2017 · Essays in Biochemistry
3. High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma
   Jintuo Zhou, Yanting Zhu, Ying Liu, Peiguang Niu, Huajiao Chen, Jie Deng, Daohua Shi · 2020 · Translational Andrology and Urology
4. Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic Nephropathy
   Alaa Abou Daher, Sahar Alkhansa, William S. Azar, Rim W. Rafeh, Hilda E. Ghadieh, Assaad Antoine Eid · 2021 · Antioxidants and Redox Signaling
5. Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1
   Amelia K. Luciano, Ekaterina D. Korobkina, Scott P. Lyons, John D. Haley, Shelagh M. Fluharty, Su Myung Jung, Arminja Nadine Kettenbach, David A. Guertin · 2022 · Journal of Biological Chemistry
6. Improvement of mTORC1-driven overproduction of apoB-containing triacylglyceride-rich lipoproteins by short-chain fatty acids, 4-phenylbutyric acid and (R)-α-lipoic acid, in human hepatocellular carcinoma cells
   Joseph L. Roberts, Bo He, Anjeza Erickson, Régis F. Moreau · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
7. Montelukast enhances cytocidal effects of carfilzomib in multiple myeloma by inhibiting mTOR pathway
   Jia Tong, Qing Yu, Wenbin Xu, Wenjun Yu, Chao Wu, Yingli Wu, Hua Yan · 2018 · Cancer Biology & Therapy
8. The endolysosomal adaptor PLEKHM1 is a direct target for both mTOR and MAPK pathways
   Andrea Gubaš, Christina Karantanou, Doris Popovic, Georg Tascher, Marina E. Hoffmann, Anna Platzek, Nina Dawe, Ivan Đikić, Daniela S. Krause, David G. McEwan · 2021 · FEBS Letters
9. Impaired Hypothalamic mTOR Activation in the Adult Rat Offspring Born to Mothers Fed a Low-Protein Diet
   O. Guzmán-Quevedo, R. da Silva Aragão, G. Pérez-García, R. Matos, A. de Sá Braga Oliveira, R. D. de Castro, F. Bolaños-Jiménez · 2013 · PLoS ONE
10. TORC1 autonomously controls its spatial partitioning via the Rag GTPase tether Tco89
    Raffaele Nicastro, Marie‐Pierre Gulli, Marco Caligaris, Malika Jaquenoud, Ladislav Dokládal, Josephine Alba, Farida Tripodi, Benjamin Pillet, Melanie Brunner, Michael Stumpe et al. · 2025 · Cell Reports
11. Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis
    Chen‐Yu Wang, Donald S. Stapleton, Kathryn L. Schueler, Mary E. Rabaglia, Angie Tebon Oler, Mark P. Keller, Christina M. Kendziorski, Karl W. Broman, Brian S. Yandell, Eric E. Schadt et al. · 2012 · Journal of Lipid Research
12. Phosphoproteomics of cAMP signaling of Bordetella adenylate cyclase toxin in mouse dendritic cells
    Jakub Novák, Ivo Fabrik, Irena Linhartová, Marek Link, Ondřej Černý, Jiří Stulík, Peter Šebo · 2017 · Scientific Reports
13. Lys05 – A Promising Autophagy Inhibitor in the Radiosensitization Battle: Phosphoproteomic Perspective
    Martin Ondrej, Lucie Čecháková, Ivo Fabrik, Jana Klimentová, Aleš Tichý · 2020 · Cancer Genomics & Proteomics
14. Insulin resistance without elevated mammalian target of rapamycin complex 1 activity in muscles of mice fed a high-fat diet
    Thomas Reynolds, Nicholas Cinquino, Marcus Anthony, Charles B. Phelps, Eli Zachary Berk · 2009 · Journal of Applied Physiology
15. Energy-Sensing Pathways in Ischemia: The Counterbalance Between AMPK and mTORC
    Ángel Enrique Céspedes-Rubio, Mario Villa, Irene Benito‐Cuesta, María José Pérez-Álvarez, Lara Ordóñez‐Gutiérrez, Francisco G. Wandosell · 2019 · Current Pharmaceutical Design
16. Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors
    Chase H. Melick, Jenna L. Jewell · 2020 · Biochemical Journal
17. Target of rapamycin (TOR) gene is vital for whitefly survival and reproduction
    Heena Puri, Vikas Jindal · 2021 · Journal of Biosciences
18. Regulation of Apoptosis and Autophagy During Anoxia in the Freshwater Crayfish, Faxonius virilis
    Sarah A. Breedon, Aakriti Gupta, Kenneth B. Storey · 2022 · Marine Biotechnology
19. The Akt Forkhead Box O Transcription Factor Axis Regulates Human Cytomegalovirus Replication
    Hongbo Zhang, Anthony J. Domma, Felicia D. Goodrum, Nathaniel J. Moorman, Jeremy P. Kamil · 2022 · mBio
20. The role of mechanistic target of rapamycin in maintenance of glomerular epithelial cells
    Yao Yao, Ken Inoki · 2015 · Current Opinion in Nephrology & Hypertension
21. The Apoptosis Regulator 14-3-3η and Its Potential as a Therapeutic Target in Pituitary Oncocytoma
    Sida Zhao, Bin Li, Chuzhong Li, Hua Gao, Yazhou Miao, Yue He, Hongyun Wang, Lei Gong, Dan Li, Yazhuo Zhang et al. · 2019 · Frontiers in Endocrinology
22. Crosstalk between the mTOR pathway and primary cilia in human diseases
    Philipp P. Prosseda, Svenja Dannewitz Prosseda, Matthew Tran, Paloma B. Liton, Yang Sun · 2023 · Current topics in developmental biology/Current Topics in Developmental Biology
23. Rapamycin improves the survival of epilepsy model cells by blocking phosphorylation of mTOR base on computer simulations and cellular experiments
    Kezhou Li, Jun‐Feng Cao, Yunli Gong, Xiong Li, Mei Wu, Yue Qi, Xiran Ying, Dengxin Liu, Xuntai Ma, Xiao Zhang · 2024 · Neurochemistry International
24. Role of PIM Kinase Inhibitor in the Treatment of Alzheimer’s Disease
    Shreyasi Meur, Swarupananda Mukherjee, Souvik Roy, Dipanjan Karati · 2024 · Molecular Neurobiology
25. NDRG1 and its family members: More than just metastasis suppressor proteins and targets of thiosemicarbazones
    Mahan Gholam Azad, Tiffany M. Russell, Xuanling Gu, Xiao Zhao, Věra Richardson, Tharushi P. Wijesinghe, Golap Babu, Xinnong Guo, Büşra Kaya, Mahendiran Dharmasivam et al. · 2025 · Journal of Biological Chemistry
26. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas
    Shichuan Tan, Ryan Spear, Juan Zhao, Xiulian Sun, Pin Wang · 2022 · Frontiers in Genetics
27. Dietary β‐sitosterol supplementation enhanced intestinal immune function of large yellow croaker ( Larimichthys crocea ) infected with Aeromonas hydrophila
    Yan Song, Zhiyuan Lu, Xiaofang Zhang, Jing Xu, Miao Gong, Lingting Meng, Zhiyuan Gong, Bin Zheng · 2022 · Aquaculture Research
28. The role of Raptor in lymphocytes differentiation and function
    Jianing Tang, Lu Yang, Fei Guan, Heather Miller, Niels Olsen Saraiva Câmara, Louisa Katherine James, Kamel Benlagha, Masato Kubo, Steffen Heegaard, Pamela P. W. Lee et al. · 2023 · Frontiers in Immunology
29. PRAS40 alleviates neurotoxic prion peptide‐induced apoptosis via mTOR‐AKT signaling
    Wei Yang, Lifeng Yang, Zhiqi Song, Syed Zahid Ali Shah, Yongyong Cui, Chaosi Li, Huafen Zhao, Hong‐Li Gao, Xiangmei Zhou, De‐Ming Zhao · 2017 · CNS Neuroscience & Therapeutics
30. CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma
    Eric Remer, Mai Badarni, Elad Hikri, Avraham Dayan, Lirit Levi, Aron Popovtzer, Muhammed Iraqi, Angel Porgador, Ben‐Zion Joshua, Gideon Y. Bachar et al. · 2020 · Journal of Clinical Medicine
31. Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy
    Nitesh Kumar Poddar, Disha Agarwal, Yamini Agrawal, Yasanandana Supunsiri Wijayasinghe, Arunima Mukherjee, Shahanavaj Khan · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
32. The skeletal muscle fiber periphery: A nexus of mTOR-related anabolism
    Cassidy T. Tinline‐Goodfellow, Matthew J. Lees, Nathan W. Hodson · 2022 · Sports Medicine and Health Science
33. The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome
    Zhang Jh, Erica M. Seigneur, M Pandey, Anna Loshakov, Pradeep Kumar Dagur, Patricia S. Connelly, Lily Y. Koo, Leelamma M. Panicker, William F. Simonds · 2012 · Cell Death and Disease
34. Mechanisms and Control of Protein Translation in the Kidney
    Valérie Schaeffer, Christine K. Abrass · 2009 · American Journal of Nephrology
35. Role of PKB/Akt in Liver Diseases
    Elena Zhuravleva, Oliver Tschopp, Brian A. Hemmings · 2009 · Springer eBooks
36. Influence of Age on Skeletal Muscle Hypertrophy and Atrophy Signaling: Established Paradigms and Unexpected Links
    Eunjoo Hwang Lee, Ronald L. Neppl · 2021 · Genes
37. Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-α (HNF1A) function in INS-1 insulinoma cells
    Angela M. Farrelly, H Wobser, Caroline Bonner, Sergio Anguissola, Markus Rehm, Caoimhín G. Concannon, Jochen H.M. Prehn, Maria M. Byrne · 2008 · Diabetologia
38. The indispensable role of the RNA helicase DDX5 in tumorigenesis induced by the myeloproliferative neoplasm-associated JAK2V617F mutant
    Kengo Takeda, Kenji Tago, Megumi Funakoshi‐Tago · 2022 · Cellular Signalling
39. TAS0612, a Novel RSK, AKT, and S6K Inhibitor, Exhibits Antitumor Effects in Preclinical Tumor Models
    K. Ichikawa, Satoshi Ito, Emi Kato, Naomi Abe, Takumitsu Machida, Junya Iwasaki, Gotaro Tanaka, Hikari Araki, Kentaro Wakayama, Hideki Jona et al. · 2023 · Molecular Cancer Therapeutics
40. Recent insights into the pathophysiology of mTOR pathway dysregulation
    Deborah A. Altomare, Sarah B. Gitto · 2015 · Research and Reports in Biology
41. Role of mTOR in the regulation of skeletal muscle metabolism
    Natalia D. Golberg, Anastasiya M. Druzhevskaya, Viktor A. Rogozkin, Ildus I. Ahmetov · 2014 · Human Physiology
42. Evolution of TOR and Translation Control
    Bruno D. Fonseca, Tyson Ernst Graber, Huy‐Dung Hoang, Asier González, Alexander A. Soukas, Greco Hernández, Tommy Alain, Stephanie Louise Swift, Ronit Weisman, Christian Meyer et al. · 2016 · Springer eBooks
43. WNK1 signalling regulates amino acid transport and mTORC1 activity to sustain acute myeloid leukaemia growth
    Shunlei Duan, Karl Agger, Jan‐Erik Messling, Koutarou Nishimura, Xuerui Han, Isabel Peña‐Rømer, Pavel V. Shliaha, Helene Damhofer, Max E. Douglas, Manas Kohli et al. · 2025 · Nature Communications
44. How is the AKT/mTOR pathway involved in cell migration and invasion?
    JINGYAO XU, SHUANGLI HAO, KAIYUE HAN, WANXI YANG, Hong Xin Deng · 2023 · Biocell
45. The effects of PKI-402 on breast tumor models’ radiosensitivity via dual inhibition of PI3K/mTOR
    Röya Gasımlı, Çağla Kayabaşı, Besra Özmen Yelken, Aycan Aşık, Fatma Söğütlü, Çağlar Çelebi, Sunde Yılmaz Süslüer, Serra Kamer, Çıgır Biray Avci, Ayfer Haydaroğlu et al. · 2023 · International Journal of Radiation Biology
46. The Target of Rapamycin: Structure and Functions
    Chang‐Chih Wu, Po‐Chien Chou, Estela Jacinto · 2012 · InTech eBooks
47. Evaluating the mTOR Pathway in Physiological and Pharmacological Settings
    Sungki Hong, Ken Inoki · 2016 · Methods in enzymology on CD-ROM/Methods in enzymology
48. S6K2 Promises an Important Therapeutic Potential for Cancer
    Nurettin İlter Sever, Sevilay Cengiz · 2018 · Future Oncology
49. Cytotoxicity of oleanane type triterpene from leaf extract of Pterospermum acerifolium (in vitro) and theoretical investigation of inhibitory signaling pathway
    Mohd Rehan, Shafiullah, Sultanat · 2020 · Chinese Herbal Medicines
50. The TORC1 phosphoproteome in C. elegans reveals roles in transcription and autophagy
    Aileen K. Sewell, Zachary C. Poss, Christopher C. Ebmeier, Jeremy R. Jacobsen, William M. Old, Min Han · 2022 · iScience
51. Fathoming the Role of mTOR in Diabetes Mellitus and its Complications
    Faheem Faheem, Shanthi Sivasubrmanian · 2022 · Current Molecular Pharmacology
52. Translational Control by Amino Acids and Energy
    Kathrin Thedieck, Michael N. Hall · 2010 · Elsevier eBooks
53. Current Phase II clinical data for ridaforolimus in cancer
    Anna Spreafico, Helen J MacKay · 2013 · Expert Opinion on Investigational Drugs
54. The mTOR Signaling Pathway in Neurodegenerative Diseases
    Arnaud Francois, Julie Vérité, Agnès Rioux Bilan, Thierry Janet, Frédéric Calon, Bernard Fauconneau, Marc Paccalin, Guylène Page · 2016 · Elsevier eBooks
55. Identification of the Novel Interacting Partners of the Mammalian Target of Rapamycin Complex 1 in Human CCRF-CEM and HEK293 Cells
    Hazır Rahman, Muhammad Qasim, Michael Oellerich, Abdul Rahman Asif · 2014 · International Journal of Molecular Sciences
56. MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1
    Xiao Li, Kai Cheng, Meng-Di Shang, Yong Yang, Bin Hu, Xi Wang, Xiao-Dan Wei, Yanchun Han, Xiaogang Zhang, Meng-Hua Dong et al. · 2024 · BMC Cancer
57. Structural and mechanistic basis of mTORC2 activation of protein kinase AKT/PKB
    Nam Ky Chu, Nhat T. T. Le, Ouada Nebie, Sammi Yang · 2026 · Biochemical Journal
58. Research Translation and Personalized Medicine
    James Brugarolas · 2012 · Springer eBooks
59. Proline-rich Akt substrate of 40-kDa contains a nuclear export signal
    Claudia Wiza, Emmani B. M. Nascimento, Margot M. L. Linssen, Françoise Carlotti, Daniella Herzfeld de Wiza, Gerard C.M. van der Zon, J. Antonie Maassen, Michaëla Diamant, Bruno Guigas, D. Margriet Ouwens · 2013 · Cellular Signalling
60. The TSC1–TSC2 Complex
    2010 · The Enzymes
61. Cellular metabolism and lysosomal mTOR signaling
    Israel C. Nnah, Khoosheh Khayati, Radek Dobrowolski · 2015 · Cell death in therapy
62. A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma
    Kian‐Huat Lim, Emma J. Langley, Feng Gao, Jingqin Rosy Luo, Lin Li, Gary E. Meyer, Phillip Kim, Sharat Singh, Vladamir M. Kushnir, Dayna S. Early et al. · 2017 · Oncotarget
63. Formal Modeling of mTOR Associated Biological Regulatory Network Reveals Novel Therapeutic Strategy for the Treatment of Cancer
    Zurah Bibi, J. Ahmad, Amnah Siddiqa, R. Paracha, Tariq Saeed, Amjad Ali, H. A. Janjua, S. Ullah, E. Ben Abdallah, Olivier F. Roux · 2017 · Frontiers in Physiology
64. Herbal cake-partitioned moxibustion inhibits colonic autophagy in Crohn’s disease via signaling involving distinct classes of phosphatidylinositol 3-kinases
    Shi-Yuan Wang, Jimeng Zhao, Ci-Li Zhou, Handan Zheng, Yan Huang, Min Zhao, Zhiying Zhang, Luyi Wu, Huangan Wu, Huirong Liu · 2020 · World Journal of Gastroenterology
65. The mTOR Pathway and Aging
    Katherine H. Schreiber, Monique N. O’Leary, Brian Keith Kennedy · 2015 · Elsevier eBooks
66. Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?
    Vincenzo Flati, Giovanni Corsetti, Evasio Pasini, Anna Rufo, Claudia Romano, Francesco Saverio Dioguardi · 2015 · Anti-Cancer Agents in Medicinal Chemistry
67. Adaptive protein synthesis in genetic models of copper deficiency and childhood neurodegeneration
    Alicia R. Lane, Noah E. Scher, Shatabdi Bhattacharjee, Stephanie A. Zlatic, Anne M. Roberts, Avanti Gokhale, Kaela S. Singleton, Duc Minh Duong, Mike McKenna, William L. Liu et al. · 2025 · Molecular Biology of the Cell
68. MTORC2 is a physiological hydrophobic motif kinase of S6 Kinase 1
    Sheikh Tahir Majeed, Rabiya Majeed, Aijaz A. Malik, Muhammad Afzal Zargar, Khurshid Iqbal Andrabi · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
69. mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
    Mehmet Küçüköner · 2013 · Dicle Medical Journal / Dicle Tip Dergisi
70. Current Coverage of the mTOR Pathway by Next-Generation Sequencing Oncology Panels
    Rita Seeboeck, Victoria Sarne, Johannes Haybaeck · 2019 · International Journal of Molecular Sciences
71. mTOR–mLST8 interaction: hot spot identification through quantum biochemistry calculations
    Francisco Lucas Santos de Oliveira, Jaqueline Vieira Carletti, Francisca Fernanda Nunes Azevedo, Francisca Joseli Freitas de Sousa, E. W. S. Caetano, V. N. Freire, Geancarlo Zanatta · 2020 · New Journal of Chemistry
72. Potential of mTOR inhibitors as therapeutic agents in hematological malignancies
    Kamalesh Kumar Sankhala, Francis Joseph Giles · 2009 · Expert Review of Hematology
73. AMPK
    Daniel Garcia, Maria M. Mihaylova, Reuben J. Shaw · 2020 · Wiley eBooks
74. Cerebellar phenotypes in germline PTEN mutation carriers
    Donatella Gambini, Stefano Ferrero, Gaetano Bulfamante, Luigi Pisani, Massimo Corbo, Elisabetta Kuhn · 2024 · Neuropathology and Applied Neurobiology
75. White Adipocyte Stem Cell Expansion Through Infant Formula Feeding: New Insights into Epigenetic Programming Explaining the Early Protein Hypothesis of Obesity
    Bodo Clemens Melnik, Ralf Weiskirchen, Swen Malte John, Wolfgang Stremmel, Claus Leitzmann, Sabine Weiskirchen, Gerd Schmitz · 2025 · International Journal of Molecular Sciences
76. LPS诱导的肺纤维细胞PTEN基因表达和Akt磷酸化蛋白表达的研究
    Mao-lin HUANG, Zhen‐Dong Yang, Lu-lu GONG, Ning Cui · 2014 · 国际中西医结合杂志
77. Somatic Variants in SVIL in Cerebral Aneurysms
    Pui Man Rosalind Lai, Jee‐Yeon Ryu, Sang‐Cheol Park, Bradley A. Gross, Lawrence D. Dickinson, Sarajune Dagen, Mohammad Ali Aziz‐Sultan, Alan S. Boulos, Daniel Louis Barrow, H. Hunt Batjer et al. · 2022 · Neurology Genetics
78. TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease
    Andrew J. McNair, Greg Robert Markby, Qiyu Tang, Vicky Elizabeth MacRae, BRENDAN M. CORCORAN · 2023 · Frontiers in Veterinary Science
79. Exercise, mTOR Activation, and Potential Impacts on the Liver in Rodents
    Giuliano Moreto Onaka, Marianna Rabelo de Carvalho, Patricia Kubalaki Onaka, Claudiane Maria Barbosa, Paula Felippe Martinez, Silvio Assis de Oliveira-Junior · 2024 · Biology
80. TOR Complexes
    Vittoria Zinzalla, Thomas Wayne Sturgill, Michael N. Hall · 2010 · The Enzymes
81. TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
    Yingbin Xie, Luyue Chen, Junhu Zhou, Qixue Wang, Chao Yang, Can Xu, Xiangyu Fan, Yanli Tan, Yanan Wang, Chunsheng Kang et al. · 2020 · Cancer Biology and Medicine
82. Regulation of TOR Signaling in Mammals
    Dudley W. Lamming, David M. Sabatini · 2010 · The Enzymes
83. Phytochemical modulation of mTOR signaling: emerging nanotechnology-driven therapeutics for rheumatoid arthritis management
    Deepa S. Mandlik, Prapti Adgaonkar, Satish K. Mandlik · 2025 · Inflammopharmacology
84. Research progress on the role of acupuncture in Alzheimer's disease based on the PI3K/AKT/mTOR signaling pathway
    Siqi Zhang, Xue Fan Gu, Miao Zhang, Ning Ding, Jing Yang, Tianyi Wang · 2026 · Journal of Alzheimer s Disease
85. The rapamycin sTORy: 50-year journey from Easter Island to the frontiers of biology and medicine
    Xia Xiao, Svetlana Dokudovskaya · 2026 · Trends in Biochemical Sciences
86. Effects of heroin self-administration and forced withdrawal on the expression of genes related to the mTOR network in the basolateral complex of the amygdala of male Lewis rats
    Marcos Ucha, David Roura‐Martínez, Raquel Santos‐Toscano, Roberto Capellán, Emilio Ambrosio, Alejandro Higuera‐Matas · 2022 · Psychopharmacology
87. Adropin increases with swimming exercise and exerts a protective effect on the brain of aged rats
    Hande Parlak, Ayşe Özkan, Osman Sinen, Mehmet Bülbül, Mutay Aslan, Ayşel Ağar · 2022 · Experimental Gerontology
88. Stage-specific regulation of undifferentiated spermatogonia by AKT1S1-mediated AKT-mTORC1 signaling during mouse spermatogenesis
    Lele Yang, Jinyue Liao, Hongying Huang, TL Lee, Huayu Qi · 2024 · Developmental Biology
89. Deciphering the intricate role of mTOR signaling and autophagy in Parkinson's disease and therapeutic prospect
    Lakshmi Narayanan, Dithu Thekkekkara, Sreenivasulu Naidu Kondaveeti, Amrita Babu, Banerjee Aniruddha Sailen, Saravana Babu Chidambaram, Santhepete Nanjundaiah Manjula · 2024 · Journal of Applied Pharmaceutical Science
90. FOXC1 transcriptionally suppresses ABHD5 to inhibit the progression of renal cell carcinoma through AMPK/mTOR pathway
    Jianfa Li, Shuangchen Chen, Jing Xiao, Jiayuan Ji, Chenchen Huang, Shu Ge · 2024 · Cell Biology and Toxicology
91. High-density lipoprotein protects normotensive and hypertensive rats against ischemia-reperfusion injury through differential regulation of mTORC1 and mTORC2 signaling
    Reham Al-Othman, Aishah Al‐Jarallah, Fawzi A. Babiker · 2024 · Frontiers in Pharmacology
92. Mechanisms of Resistance to PI3K and AKT Inhibitors
    Pau Castel, Maurizio Scaltriti · 2018 · Resistance to targeted anti-cancer therapeutics
93. Understanding intrinsic survival and regenerative pathways through in vivo and in vitro studies: implications for optic nerve regeneration
    Toshiyuki Oshitari · 2021 · Expert Review of Ophthalmology
94. Regulation of mTOR complexes in long-lived growth hormone receptor knockout and Snell dwarf mice
    Xiaofang Shi, S. Joseph Endicott, Richard A. Miller · 2022 · Aging
95. DEPTOR loss impairs brown adipocyte development in vitro but has limited impacts in mice
    Charles Colas, Mathilde Mouchiroud, Manal Al Dow, Alona Kolnohuz, Yves Gélinas, Alexandre Caron, Mathieu Laplante · 2022 · Molecular Metabolism
96. mTORC1 Signaling and Hypoxia
    James Brugarolas · 2009 · Humana Press eBooks
97. Actions and interactions of AMPK with insulin, the peroxisomal-proliferator activated receptors and sirtuins
    Mark J. Holness, Peter H. Sugden, Marta Paulino Silvestre, Mary C. Sugden · 2012 · Expert Review of Endocrinology & Metabolism
98. PI(3)K–Akt–mTOR pathway as a potential therapeutic target in neuroendocrine tumors
    Kathrin Zitzmann, George Vlotides, Burkhard Göke, Christoph Josef Auernhammer · 2008 · Expert Review of Endocrinology & Metabolism
99. Understanding the complex role of mTORC as an intracellular critical mediator of whole-body metabolism in anorexia nervosa: A mini review.
    2021 · Acta bio-medica dell'Ateneo parmense/Acta biomedica